Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

FLUCAINE

×

Overview

What is FLUCAINE?

EACH mL CONTAINS:

PRESERVATIVE: Methylparaben 0.1%.



What does FLUCAINE look like?



What are the available doses of FLUCAINE?

Sorry No records found.

What should I talk to my health care provider before I take FLUCAINE?

Sorry No records found

How should I use FLUCAINE?

For procedures requiring a disclosing agent in combination with an anesthetic agent such as tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures.

Usual Dosage:

Deep Ophthalmic Anesthesia:

NOTE:


What interacts with FLUCAINE?

Sorry No Records found


What are the warnings of FLUCAINE?

Sorry No Records found


What are the precautions of FLUCAINE?

Sorry No Records found


What are the side effects of FLUCAINE?

Occasional temporary stinging, burning, and conjunctival redness have been reported after use of ocular anesthetics, as well as a rare, severe, immediate-type, apparent hyper-allergic corneal reaction, with acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and sometimes, iritis with descementitis.  Allergic contact dermatitis with drying and fissuring of the fingertips has been reported.

To report SUSPECTED ADVERSE REACTIONS, contact Altaire Pharmaceuticals, Inc. at (631) 722-5988.


What should I look out for while using FLUCAINE?

Known hypersensitivity to any component of this product.

Avoid contamination - do not touch tip of sterile dropper used to dispense solution to any surface.  Replace container closure immediately after using.  Prolonged use of a topical ocular anesthetic is not recommended.  It may product permanent corneal opacification with accompanying visual loss.


What might happen if I take too much FLUCAINE?

Sorry No Records found


How should I store and handle FLUCAINE?

Storage and HandlingStore at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature). For the oral solution, use within 45 days of first opening the bottle.Storage and HandlingStore at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature). For the oral solution, use within 45 days of first opening the bottle.Fluorescein Sodium and Proparacaine Hydrochloride Ophthalmic Solution, USP (Sterile) is supplied in a glass or plastic bottle with a controlled tip applicator in the following sizes:5 mL fill (glass bottle) / 5 mL fill (10 mL plastic bottle)Fluorescein Sodium and Proparacaine Hydrochloride Ophthalmic Solution, USP (Sterile) is supplied in a glass or plastic bottle with a controlled tip applicator in the following sizes:5 mL fill (glass bottle) / 5 mL fill (10 mL plastic bottle)


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

This product is the combination of a disclosing agent with a rapidly acting anesthetic of short duration.

Non-Clinical Toxicology
Known hypersensitivity to any component of this product.

Avoid contamination - do not touch tip of sterile dropper used to dispense solution to any surface.  Replace container closure immediately after using.  Prolonged use of a topical ocular anesthetic is not recommended.  It may product permanent corneal opacification with accompanying visual loss.

This product should be used cautiously and sparingly in patients with known allergies, cardiac disease, or hyperthyroidism.  The long-term toxicity is unknown; prolonged use may possibly delay wound healing.  Although exceedingly rare with ophthalmic application of local anesthetics, it should be borne in mind that systemic toxicity manifested by central nervous system stimulation followed by depression may occur.  Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of anesthesia is very important.  Tonometers soaked in sterilizing or detergent solutions should be thoroughly rinsed with sterile distilled water prior to use.  Patients should be advised to avoid touching the eye until the anesthesia has worn off.

Occasional temporary stinging, burning, and conjunctival redness have been reported after use of ocular anesthetics, as well as a rare, severe, immediate-type, apparent hyper-allergic corneal reaction, with acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and sometimes, iritis with descementitis.  Allergic contact dermatitis with drying and fissuring of the fingertips has been reported.

To report SUSPECTED ADVERSE REACTIONS, contact Altaire Pharmaceuticals, Inc. at (631) 722-5988.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).